Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns more than 40 autonomous industrial businesses operating across research, aerospace, energy, medical, and manufacturing... Show more
AMETEK, Inc. operates as a global leader in differentiated electronic instruments and electromechanical devices, serving critical industries including aerospace and defense, medical, energy, and industrial automation. Its two primary segments—Electronic Instruments (EIG) and Electromechanical (EMG)—benefit from strong competitive advantages rooted in proprietary technology, high barriers to entry, and a track record of operational excellence through the company’s established growth model of new product development, market expansion, and targeted acquisitions.
Medium-term positioning emphasizes innovation in areas such as precision measurement, power management, and automation solutions, enabling AMETEK to maintain or grow market share in high-value niches. The firm’s disciplined capital allocation supports bolt-on acquisitions that enhance technological capabilities and geographic reach, while its diversified end-market exposure provides a buffer against sector-specific volatility. Structural risks include dependency on cyclical industrial and aerospace demand as well as the need for successful integration of acquired businesses to sustain margin expansion.
Key upcoming catalysts include the next quarterly earnings release, which will provide updated visibility into order trends and segment performance following the company’s recent guidance raise. Product launches in advanced analytical instruments and precision motion systems could drive incremental revenue and reinforce technological leadership.
Potential regulatory approvals or defense contract wins in aerospace and military applications may unlock new revenue streams, while ongoing capital allocation decisions—such as share repurchases or additional mergers and acquisitions (M&A)—could signal management’s confidence in future cash generation. Analyst rating changes and price-target revisions from major firms will also influence sentiment, with consensus currently reflecting moderate optimism based on the company’s growth trajectory and raised 2026 outlook. These events matter because they offer concrete data points that can shift earnings expectations and valuation multiples in a forward-looking manner.
Broader forces shaping AMETEK’s trajectory include interest rate trends that influence customer capital spending on industrial equipment and automation, as well as inflation pressures on input costs and pricing power. Defense and aerospace spending cycles, driven by geopolitical developments, directly benefit the company’s high-margin instrumentation offerings.
Technology adoption trends in electrification, data center power management, and medical diagnostics support long-term demand, while regulatory climates in environmental and safety standards may accelerate replacement cycles for advanced instruments. Commodity price fluctuations, particularly in energy markets, could affect EMG segment volumes, and global supply chain stability remains a variable that could either facilitate or constrain growth depending on macroeconomic conditions.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality. For additional insights, explore the Trend Prediction Engine.
Looking to 2026 and beyond, AMETEK’s outlook centers on sustained market expansion in aerospace, defense, and industrial automation, supported by its acquisition pipeline and new product development initiatives. Cost structure evolution through operational efficiencies and scale from recent acquisitions should help maintain or improve margins, while technology transitions toward more sophisticated sensors and controls align with broader industry shifts in electrification and digitalization.
Competitive threats from larger industrial conglomerates or specialized entrants will require continued innovation, and regulatory developments in medical and environmental sectors could create both opportunities and compliance costs. Capital allocation priorities are expected to balance organic growth, M&A, and shareholder returns, with consensus analyst expectations for mid-single-digit revenue growth and mid-to-high single-digit earnings expansion providing a baseline for long-term sentiment. Market assumptions around steady global industrial recovery and defense budgets will likely influence how these themes translate into valuation multiples over the medium term.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a manufacturer of electronic instruments and electromechanical devices
Industry IndustrialMachinery
A.I.dvisor indicates that over the last year, AME has been closely correlated with ROP. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if AME jumps, then ROP could also see price increases.
| Ticker / NAME | Correlation To AME | 1D Price Change % |
|---|---|---|
| AME | 100% | -0.89% |
| AME (3 stocks) | 89% Closely correlated | -0.44% |
| Producer Manufacturing (350 stocks) | 10% Poorly correlated | +0.14% |
The Moving Average Convergence Divergence (MACD) for AME turned positive on July 22, 2026. Looking at past instances where AME's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on July 21, 2026. You may want to consider a long position or call options on AME as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AME advanced for three days, in of 331 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 290 cases where AME Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AME declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AME broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. AME’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.216) is normal, around the industry mean (6.371). P/E Ratio (37.459) is within average values for comparable stocks, (78.611). Projected Growth (PEG Ratio) (3.271) is also within normal values, averaging (2.229). Dividend Yield (0.005) settles around the average of (0.018) among similar stocks. P/S Ratio (7.508) is also within normal values, averaging (141.105).